These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 10155056)

  • 1. Development of a method for the analysis of warfarin and metabolites in plasma and urine.
    de Vries JX; Schmitz-Kummer E
    Am Clin Lab; 1995 Jul; 14(7):20-1. PubMed ID: 10155056
    [No Abstract]   [Full Text] [Related]  

  • 2. Warfarin metabolites: the anticoagulant activity and pharmacology of warfarin alcohols.
    Lewis RJ; Trager WF; Robinson AJ; Chan KK
    J Lab Clin Med; 1973 Jun; 81(6):925-31. PubMed ID: 4710371
    [No Abstract]   [Full Text] [Related]  

  • 3. Determination of phenprocoumon, warfarin and their monohydroxylated metabolites in human plasma and urine by liquid chromatography-mass spectrometry after solid-phase extraction.
    Ufer M; Kammerer B; Kirchheiner J; Rane A; Svensson JO
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Oct; 809(2):217-26. PubMed ID: 15315768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Warfarin metabolism in man: identification of metabolites in urine.
    Lewis RJ; Trager WF
    J Clin Invest; 1970 May; 49(5):907-13. PubMed ID: 5441544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of warfarin enantiomers and hydroxylated metabolites in human blood plasma by liquid chromatography with achiral and chiral separation.
    Locatelli I; Kmetec V; Mrhar A; Grabnar I
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Apr; 818(2):191-8. PubMed ID: 15734158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The metabolic fate of warfarin: studies on the metabolites in plasma.
    Lewis RJ; Trager WF
    Ann N Y Acad Sci; 1971 Jul; 179():205-12. PubMed ID: 5285375
    [No Abstract]   [Full Text] [Related]  

  • 7. Simultaneous determination of warfarin enantiomers and its metabolite in human plasma by column-switching high-performance liquid chromatography with chiral separation.
    Uno T; Niioka T; Hayakari M; Sugawara K; Tateishi T
    Ther Drug Monit; 2007 Jun; 29(3):333-9. PubMed ID: 17529891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Supercritical fluid chromatography-tandem mass spectrometry for fast bioanalysis of R/S-warfarin in human plasma.
    Coe RA; Rathe JO; Lee JW
    J Pharm Biomed Anal; 2006 Nov; 42(5):573-80. PubMed ID: 16875793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study on warfarin plasma concentration and its correlation with international normalized ratio.
    Sun S; Wang M; Su L; Li J; Li H; Gu D
    J Pharm Biomed Anal; 2006 Sep; 42(2):218-22. PubMed ID: 16860509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The development and application of a surface plasmon resonance-based inhibition immunoassay for the determination of warfarin in plasma ultrafiltrate.
    Fitzpatrick B; O'Kennedy R
    J Immunol Methods; 2004 Aug; 291(1-2):11-25. PubMed ID: 15345301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of free concentrations of highly protein-bound warfarin in plasma by ultra performance liquid chromatography-tandem mass spectrometry and its correlation with the international normalized ratio.
    Huang C; Yang J; Du Y; Miao L
    Clin Chim Acta; 2008 Jul; 393(2):85-9. PubMed ID: 18406352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new high-performance liquid chromatographic method for determination of warfarin enantiomers.
    Osman A; Arbring K; Lindahl TL
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Nov; 826(1-2):75-80. PubMed ID: 16143572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biliary and urinary excretion of [14C]warfarin in rabbits.
    Wong LT; Solomonraj G
    Xenobiotica; 1980 Mar; 10(3):201-10. PubMed ID: 7467404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significant pharmacokinetic and pharmacodynamic interaction of warfarin with the NO-independent sGC activator HMR1766.
    Oberwittler H; Hirschfeld-Warneken A; Wesch R; Willerich H; Teichert L; Lehr KH; Ding R; Haefeli WE; Mikus G
    J Clin Pharmacol; 2007 Jan; 47(1):70-7. PubMed ID: 17192504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma half-lives, plasma metabolites and anticoagulant efficacies of the enantiomers of warfarin in man.
    Hewick DS; McEwen J
    J Pharm Pharmacol; 1973 Jun; 25(6):458-65. PubMed ID: 4146584
    [No Abstract]   [Full Text] [Related]  

  • 16. Sensitive determination of monoterpene alcohols in urine by HPLC-FLD combined with ESI-MS detection after online-solid phase extraction of the monoterpene-coumarincarbamate derivates.
    Meesters RJ; Duisken M; Jähnigen H; Hollender J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Nov; 875(2):444-50. PubMed ID: 18845490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enantioseparation of warfarin and its metabolites by capillary zone electrophoresis.
    Zhou Q; Yau WP; Chan E
    Electrophoresis; 2003 Aug; 24(15):2617-26. PubMed ID: 12900874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical applications of a quantitative high-pressure liquid chromatographic assay of warfarin and its metabolites.
    Fasco MJ; Piper LJ; Kaminsky LS
    J Chromatogr; 1977 Jan; 131():365-73. PubMed ID: 853101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New high-performance liquid chromatography method for the determination of (R)-warfarin and (S)-warfarin using chiral separation on a glycopeptide-based stationary phase.
    Malakova J; Pavek P; Svecova L; Jokesova I; Zivny P; Palicka V
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Oct; 877(27):3226-30. PubMed ID: 19643683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sodium warfarin.
    O'Reilly RA
    Pharmacology; 1972; 8(1):181-90. PubMed ID: 4644647
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.